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Ataxin-1 (ATXN1) is a gene that in healthy humans contains 4-39 repeats of the CAG 
trinucleotide which codes for the amino acid glutamine. Genes with variable number of repeats 
in their coding sequence are called “advantageous mutators”, as change in the number of repeats 
may lead to a change in their function. For example, over 40 or  more CAG repeats in ATXN1 
will  cause a neurodegenerative disorder called spinocerebellar ataxia type 1 (SCA1) (Banfi et 
al., 1994). SCA1 is characterized by motor deficits such as lack of motor control and speech 
misarticulation (Harding, 1982) as well as by cognitive deficits, such as impaired executive 
function. Intriguingly, the deletion of ATXN1 is associated with lower IQs and autism spectrum 
disorders (Celestino-Soper et al., 2012) indicating that ATXN1 may play a role in cognition. 
SCA1 null mice showed significant impairments on the spatial Morris water maze test (Matilla et 
al., 1998), reiterating that the deletion of ATXN1 may lead to learning deficits.   
In addition to causing SCA1, ATXN1 was found to have a correlation with Alzheimer’s 
disease (AD) in a genome wide association study (GWAS) (Zhang et al., 2010). AD is a fatal 
neurological disease associated with cognitive impairment and is the sixth leading cause of death 
in the United States (“US Death Rates from Alzheimer’s Disease”, 2017). A GWAS is an 
investigation into the association of genetic variants with particular traits. In this specific case, 
AD was the trait and ATXN1 was the genetic variant. Although the correlation between ATXN1 
and AD has been established in multiple studies (Zhang et al., 2010; Bettens et al., 2010), there 
have been no examinations of the correlation between the number of CAG repeats and 
occurrence of AD using human DNA. In this project, we analyzed human DNA sequences for 
the number of CAG repeats in order to determine whether a correlation between number of CAG 
repeats and AD exists. This was accomplished by analyzing DNA sequences to determine 
number of CAG repeats in Atxn1 obtained from three different groups - AD patients, patients 
with mild cognitive impairment who are at a greater risk for acquiring AD, and control healthy 
individuals. We hypothesized that the number of CAG trinucleotide repeats in the DNA 
sequence is directly proportional to the incidence of AD because CAG repeats have already 
shown to be correlated with the onset of cognitive impairments in SCA1 (Banfi et al., 1994). 
Materials and Methods 
DNA Sequences  
DNA from three different groups of individuals of ages 65 and above - individuals with AD, 
individuals with mild cognitive impairment, and healthy individuals that served as the control 
group - was obtained from the Dr. Ling Lee Laboratory. 5 samples from each group were 
obtained, with a total of 15 DNA sequences analyzed.  
DNA Sequencing 
The DNA corresponding to CAG repeat containing region of ATXN1 was amplified using 
polymerase chain reaction (PCR). The primers used to amplify this repeat region were Rep-
1/Rep-2 (Orr et al., 1993). Agarose gel electrophoresis was performed and the fluorescent bands 
were excised from the gel. DNA sequencing was performed by dideoxynucleotide chain 
termination method using a Zymoclean Gel DNA Recovery Kit (Zymo Research). Sequencing 
was completed by the University of Minnesota Genomic Center. 
Results 
15 DNA sequences from the three different groups were analyzed, with five samples in each 
group. The mean number of CAG repeats increased from the normal group to the group with 
mild cognitive impairment and increased further in the AD group (Figure 1). There was no 
significant difference of number of CAG repeats between the three groups, with a p value of 
0.215 obtained from a one-way ANOVA.  
 
Figure 1. Number of CAG repeats for DNA sequences from normal individuals, individuals 
with MCI, and individuals with AD. One-way ANOVA (p = 0.215) showed that there was 
no significant difference between the three groups.  
Discussion 
A correlation between AD and ATXN1 has been established in multiple studies (Zhang et al., 
2010; Bettens et al., 2010), but there have been no studies exploring the correlation of the 
number of CAG repeats and occurrence of AD. Here we analyzed DNA sequences from three 
different groups of individuals above the age of 65 - individuals with AD, individuals with mild 
cognitive impairment, and healthy individuals. Although the results of this experiment were not 
statistically significant, an increase in the number of CAG repeats has been proven to be 
associated with SCA1 and Huntington’s disease (Banfi et al., 1994). These findings warrant a 
further examination of the correlation between CAG repeats and AD, in which the sample size 
should be increased in order to conduct a more conclusive analysis. 
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